These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20111975)

  • 1. The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.
    Slobodin G; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M
    Clin Rheumatol; 2010 Jul; 29(7):793-4. PubMed ID: 20111975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab for the treatment of ankylosing spondylitis.
    Sieper J; Rudwaleit M; Braun J
    Expert Opin Pharmacother; 2007 Apr; 8(6):831-8. PubMed ID: 17425478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.
    Goh L; Samanta A
    Rheumatol Int; 2009 Aug; 29(10):1123-35. PubMed ID: 19562344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ankylosing spondylitis with pamidronate: an open label study.
    Grover R; Shankar S; Aneja R; Marwaha V; Gupta R; Kumar A
    Ann Rheum Dis; 2006 May; 65(5):688-9. PubMed ID: 16611869
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab.
    Korsten P; Sweiss NJ; Nagorsnik U; Niewold TB; Gröne HJ; Gross O; Müller GA
    Am J Kidney Dis; 2010 Dec; 56(6):e17-21. PubMed ID: 20974510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
    Davis JC; Huang F; Maksymowych W
    Rheum Dis Clin North Am; 2003 Aug; 29(3):481-94, viii. PubMed ID: 12951863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report].
    Azevedo VF; Pietrovski CF; de Almeida Santos M
    Reumatismo; 2010; 62(4):283-5. PubMed ID: 21253622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.
    Toussirot E; Wendling D
    Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database.
    Wendling D; Joshi A; Reilly P; Jalundhwala YJ; Mittal M; Bao Y
    Curr Med Res Opin; 2014 Dec; 30(12):2515-21. PubMed ID: 25252590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open study of pamidronate in the treatment of refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Leclercq S; Skeith K; Yan A; Russell AS
    J Rheumatol; 1998 Apr; 25(4):714-7. PubMed ID: 9558174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases.
    Toussirot E; Le Huédé G; Lohse A; Cédoz JP; Wendling D
    Clin Exp Rheumatol; 2006; 24(3):348. PubMed ID: 16870109
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of active ankylosing spondylitis with pamidronate.
    Haibel H; Brandt J; Rudwaleit M; Soerensen H; Sieper J; Braun J
    Rheumatology (Oxford); 2003 Aug; 42(8):1018-20. PubMed ID: 12869678
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
    Revicki DA; Luo MP; Wordsworth P; Wong RL; Chen N; Davis JC;
    J Rheumatol; 2008 Jul; 35(7):1346-53. PubMed ID: 18484692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological treatment of ankylosing spondylitis].
    Freiesleben S; Schou M
    Ugeskr Laeger; 2008 Jun; 170(24):2140-5. PubMed ID: 18565298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Santra G; Sarkar RN; Phaujdar S; Banerjee S; Siddhanta S
    Singapore Med J; 2010 Nov; 51(11):883-7. PubMed ID: 21140116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.
    Rudwaleit M; Van den Bosch F; Kron M; Kary S; Kupper H
    Arthritis Res Ther; 2010; 12(3):R117. PubMed ID: 20553600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Behçet's disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis.
    Chung SH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    World J Gastroenterol; 2013 Aug; 19(32):5389-92. PubMed ID: 23983446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
    Kang KY; Lee KY; Kwok SK; Ju JH; Park KS; Hong YS; Kim HY; Park SH
    Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.
    Cairns AP; Wright SA; Taggart AJ; Coward SM; Wright GD
    Ann Rheum Dis; 2005 Feb; 64(2):338-9. PubMed ID: 15096328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.